Solventum Corporation (SOLV) - Yahoo Finance

ELV Elevance Health, Inc. 414.01. +2.03%. Find the latest Solventum Corporation (SOLV) stock quote, history, news and other vital information to help you with your stock trading and investing.

CouponFollow Extension

03%
OFF

Solventum Corporation (SOLV) - Yahoo Finance

1 week from now

ELV Elevance Health, Inc. 414.01. +2.03%. Find the latest Solventum Corporation (SOLV) stock quote, history, news and other vital information to help you with your stock trading and investing.

yahoo.com

20%
OFF

Solventum Corporation (SOLV) - Yahoo Finance

1 week from now

OTIS Otis Worldwide Corporation. 101.26. -1.20%. ELV Elevance Health, Inc. 425.27. +1.49%. Find the latest Solventum Corporation (SOLV) stock quote, history, news and other vital …

yahoo.com

$6161
OFF

Decoding Solventum Corp (SOLV): A Strategic SWOT Insight

1 week from now

Nov 9, 2024 · While Solventum Corp reported a slight increase in total net sales from $6,161 million in the first nine months of 2023 to $6,179 million in the same period of 2024, its net …

yahoo.com

26%
OFF

Solventum Corporation (SOLV) - Yahoo Finance

1 week from now

Solventum Corporation (NYSE:SOLV) Shares Could Be 26% Below Their Intrinsic Value Estimate Simply Wall St. • 3 months ago Solventum to Report Second Quarter 2024 Financial Results …

yahoo.com

1%
OFF

SOLV Stock Falls Despite Launch Of Clarity Precision Grip …

1 week from now

1 day ago · SOLV’s shares plunged 3.1% on Nov. 14, continuing its month-long downtrend, despite the launch. The stock fell 1.7% since its IPO on April 1, 2024, compared with the …

yahoo.com

$73
OFF

Solventum Price Target Raised To $73 From $60 At Morgan Stanley

1 week from now

5 days ago · Morgan Stanley raised the firm’s price target on Solventum (SOLV) to $73 from $60 and keeps an Equal Weight rating on the shares. ... Yahoo Finance Yahoo Finance . Search …

yahoo.com

FAQs about Solventum Corporation (SOLV) - Yahoo Finance Coupon?

Should you buy solventum (Solv) stock?

According to 9 analysts, the average rating for SOLV stock is "Hold." The 12-month stock price forecast is $64.33, which is a decrease of -5.54% from the latest price. ST. PAUL, Minn. , Oct. 10, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that Dr. Ryan Egeland, MD, has been named chief medical officer. ...

What's going on with solventum Corp (Solv)?

Threats: Intense competition and regulatory challenges in the healthcare sector. On November 8, 2024, Solventum Corp (NYSE:SOLV), an independent healthcare company, released its 10-Q filing, providing a snapshot of its financial health and strategic positioning. This SWOT analysis delves into the company's financials, revealing a mixed picture. ...

How did solventum Corp perform in 2023?

This SWOT analysis delves into the company's financials, revealing a mixed picture. While Solventum Corp reported a slight increase in total net sales from $6,161 million in the first nine months of 2023 to $6,179 million in the same period of 2024, its net income took a significant hit, dropping from $1,074 million to $448 million. ...

What is solventum Corporation?

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. ...

What was the closing price of solventum's common stock on June 6 2024?

The closing stock price of Solventum's common stock on June 6, 2024 was $55.05. Solventum (NYSE: SOLV) today reported carve-out financial results for the first quarter ended March 31, 2024. Solventum (NYSE: SOLV) announced today that it will release carve-out financial results for the first quarter 2024 before the market opens on May 9, 2024. ...

Will solventum Solv (Solv) stock surge after Trump retakes the White House?

Stocks surge after Trump retakes the White House. Follow our live blog. Solventum SOLV is scheduled to release third-quarter 2024 results on Nov. 7, after market close. In the last reported quarter, the company’s earnings beat the Zacks Consensus Estimate by 6.85%. SOLV delivered a trailing four-quarter average earnings surprise of 15.7%. ...